<DOC>
	<DOCNO>NCT02726646</DOCNO>
	<brief_summary>Summary The aim study evaluate clinical , microbiological immunological parameter use PLGA microspheres ( lactic-co-glycolic acid polyacid ) contain doxycycline periodontal therapy smoker chronic periodontitis . For study , 40 patient select , average age 30 59 year old gender ( male female ) , spontaneously seek clinic graduate Piracicaba Dental School -FOP / UNICAMP , exhibit least four bleeding site , include 2 site probe depth ( PD ) 5 6 mm two site PS ≥7 mm uniradiculares teeth . Patients minimum 20 teeth . Will exclude relevant systemic disease carrier antibiotic use 6 month precede study . All patient receive oral hygiene instruction undergo pre-treatment , hold supragingival sweep removal plaque retentive factor . Patients divide 2 group ( DB + DOX : Debridement + Doxycycline , test group DB : debridement , control group ) 20 patient receive follow treatment : periodontal debridement ultrasound 45 minute associate local administration 1 mg microspheres contain doxycycline , mechanical debridement , select site . Will assess follow clinical parameter : gingival index ( GI ) Plaque Index ( PI ) , Bleeding Probing ( BOP ) , Position gingival margin ( PGM ) , Probing Depth ( PD ) Relative Clinical Attachment Level ( RCAL ) . The microbiological evaluation make mean polymerase chain reaction - real time ( `` real time '' - PCR ) detect bacteria : Porphyromonas gingivalis , Tannerella forsythia , Treponema denticola , Aggregatibacter actinomycetemcomitans Prevotella intermedia . The enzyme immunoassay ( LUMINEXMAGPIX ) allow detection cytokine level GM-CSF , INF-γ , IL-10 , IL-12 , IL-13 , IL-1β , IL-4 , IL-6 , IL-8 TNF-α . The analysis proteolytic enzyme activity accomplish use zymography assess MMP-8 MMP-9 . The described parameter evaluate baseline , 45 90 day initial visit . The result compare statistically analysis variance repeat measure 5 % significance level .</brief_summary>
	<brief_title>Evaluation Local Doxycycline Smokers With Chronic Periodontitis</brief_title>
	<detailed_description>VI- Methods 1 . Sample Selection After submission approval project Research Ethics Committee ( CEP ) Piracicaba Dental School - UNICAMP , select among patient seek spontaneously treatment clinic Graduate FOP-UNICAMP ( also perform clinical phase study ) , 40 patient average age 30 59 year , gender ( male female ) accord follow inclusion criterion : - Patients smoker , overall good health - patient initially diagnose moderate severe chronic periodontitis ( accord American Academy Periodontology- AAP , 1999 ) verify presence radiographic periodontal pocket bone loss ; - Patients least four bleed site probe depth ( PD ) &gt; 5 mm uniradiculares teeth . - Presence minimum 20 teeth ; - formal consent participate research , explain risk benefit individual involve . ( Resolution No . 196 October 1996 Dental Code Professional Ethics ( C.F.O . ) 179/93 ) . The exclusion criterion : - periapical pulp change Presence - Presence systemic change use medication ( 6 month prior study ) may influence response periodontal treatment ( eg , phenytoin , cyclosporine , calcium channel antagonist , anti-inflammatory steroid non-steroidal ) ; - Presence hypersensitivity tetracyclines derivative ; - Teeth involvement furcation case premolar . - Pregnancy lactation 2 . Study design The study clinical , randomize , control , double-blind , parallel design , treatment randomly distribute among patient . Selected patient divide 2 group , whose teeth receive treatment , follow : DB group ( 20 patient ) , - mechanical debridement one session application placebo microspheres four periodontal pockts great 5 mm DB + DOX group ( 20 patient ) , - mechanical debridement one session associate application 1 mg microspheres load doxycycline per periodontal pockt , four site equal great 5 mm . The PLGA microspheres , use study control drug delivery system , produce Biomaterials Laboratory Medicine Catholic University São Paulo , accord Moura , 2015 . The microspheres load doxycycline hydrochloride ( EMS Sigma Pharma-Generics , Hortolandia , Brazil ) . 3 . Research Plan Initial examination : Selection 40 patient accord pre-established criterion . Initial therapy : All patient educate cause consequence periodontal disease well importance prevention technique , ( sulcular brush floss ) periodontal therapy . In phase , supragingival periodontal debridement mouth removal plaque retentive factor . Treatment : All patient treat subgingival debridement mouth operator reassess 3 month study investigator . Randomization perform list generate computer . Reviews treatment : Patients instructed oral hygiene hold professional control supragingival biofilm follow-up visit . To standardize location collection clinical data , guide probe device make - `` stent '' acrylic sheet 1mm thick vacuum plasticizing , survey site PS≥ 7 mm . Clinical : The clinical parameter : 1 . Gingival Index - IG ( Löe Silness , 1963 ) : Inflammatory signal collect follow score : 0 ( absence gingival inflammation ) ; 1 ( mild inflammation - small change color , texture , absence bleed probe ) ; 2 ( moderate inflammation - moderate brightness , redness , swell hypertrophy , bleed probe ) ; 3 ( severe inflammation - marked redness hypertrophy ; spontaneous bleeding , tendency ulceration ) 2 . Plaque Index - IP ( Ainamo &amp; Bay , 1975 ) : Evaluation presence / absence plaque binominal standard . Number face engage plate divide number present face patient 's teeth 0- visible plaque ; 1- presence visible plaque 3 . Bleeding probe - SS ( Mühlemann &amp; Son , 1971 ) : Standard dichotomous . 0-absence bleeding ; 1- presence bleeding . 4. position gingival margin - PMG : distance demarcation `` stent '' free gingival margin . e Insertion Relative Clinical Level - NICR : distance demarcation `` stent '' base , clinically detectable , periodontal pocket . f- Depth Survey - PS ( NICR - PMG ) : distance gingival margin base , clinically detectable , periodontal pocket . All clinical parameter obtain use periodontal probe North Carolina type baseline , 45 90 day . Description method affect research subject : Once select study volunteer , receive guideline relate Consent Informed research follow recommendation Resolution 466/12 CNS . Any discomfort may cause periodontal debridement treatment ultrasound different cause treatment coronorradicular scraping , consist moderate pain treat area possibility dentine hypersensitivity due exposure dentinal tubule root surface . To minimize possible discomfort volunteer prescribe aftertreatment analgesic mouthwash fluoride solution case , regardless whether feature dentinal hypersensitivity . Local administration antibiotic ( doxycycline ) pose risk volunteer , since administer dose cause local effect , accord study consult preparation project . Moreover , even undesirably administer antibiotic achieve expect result , say result patient exposure kind risk , since dose give insufficient cause increase discomfort . Still , conventional treatment without local use antibiotic yield result patient , benefit method oral hygiene education clarification oral health , contribute improve quality life patient . Microbiological evaluation : It do polymerase chain reaction ( PCR ) `` real time '' . This test allow quantitative detection follow bacteria : Porphyromonas gingivalis , Tannerella forsythia , Treponema denticola , Aggregatibacter actinomycetemcomitans Prevotella intermedia , hold Discipline Periodontology Laboratories , locate FOP / UNICAMP . 1. collection subgingival The area collection material , properly insulate dry sterile cotton roll . The portion supragingival bacterial biofilm remove obtain sample subgingival plaque , place strip paper ( Periopaper - ( OraFlow Inc. , New York , USA ) ) inside bag moderate ( 5-6 mm ) deep pocket ( ≥ 7 mm ) patient , 45 - 60 second . The volume gingival crevicular fluid collect measured Periotron 8000 ( OraFlow Inc. , New York , USA ) paper strip place microcentrifuge tube ( Eppendorf ) , cod patient , 400 200l phosphate buffer saline ( PBS ) 0.05 % Tween-20 . 2 . DNA Purification The bacterial strain obtain American Type Culture Collection ( ATCC ) P. intermedia ( Pi ) ( ATCC 25611 ) , P. gingivalis ( Pg ) ( ATCC 33277 ) , A. actinomycetemcomitans ( Aa ) ( ATCC 29522 ) culture pure T. denticola ( Td ) T.forsythia ( TF ) use positive control standard . The bacterial DNA purify use DNA isolation kit PowerSoil® ( MO BIO Laboratories , Inc. ) . The DNA concentration adjust 15 ng / ul water additional six dilution 10-fold serial make . Three replicate sample dilution ( 5 ul / sample ) assay describe specific DNA . The sensitivity assay determine low dilution DNA produce statistically significantly low ( p &lt; 0.001 ) high control without template use t-test . 3. real PCR team DESIGN OF PRIMERS : The `` primer '' specific intermediate P. , P. gingivalis , A. actinomycetemcomitans , T. T. forsythensis denticola use . All `` primer '' check specificity verify Melting curve ( obtain run LightCycler ) run gel product verification . OPTIMIZATION OF REACTIONS : The use SYBR Green I require get specific PCR product , basis effectiveness responses `` primer '' optimized start actual reaction . Concentrations range 2 5 mM MgCl 2 0,2 0,5 uM `` primer '' use determine reaction condition best efficiency . These condition suggest manufacturer equipment . REACTIONS OF REAL-TIME PCR ( RT-PCR ) : The RT-PCR reaction perform LightCycler system ( Roche DiagnosticsGmbH , Mannheim , Germany ) use kit `` FastStart DNA Master SYBR Green I ( Roche DiagnosticsCo . ) `` . The profile reaction determine follow equipment manufacturer 's recommendation . For `` race '' Aqua use negative control , product reaction quantify use manufacturer 's program ( Software LightCyclerRelativeQuantification - DiagnosticsGmbH Roche ) . immunoenzymatic evaluation gingival crevicular fluid For comprehensive analysis immune-inflammatory marker present gingival crevicular fluid collect periodontal site , use Luminex / Magpix system identification quantification inflammatory marker : IL-1β , IL-4 , IL-6 , IL 8 , IL-10 , IL-17 , IL-23 , TGF-β , TNF-alfa , IFN-alfa GM-CSF . For analysis , add bead label sample monoclonal antibody specific marker quantify . After addition bead , sample hybridize placed plate incubate 2 hour 37 ° C. The plate wash secondary antibody join substrate ( biotin ) add . This assembly incubated 1 hour , wash , fluorescent marker ( Streptavidin / R-phycoerythrin ) . The plate analyze Luminex 100 instrument program ( MiraiBio , Alameda , CA , USA ) . This identify quantify fluorescence bead , correspond inflammatory marker . This fluorescence transform , mean standard curve ( third-orderpolynomialequation ) value process pg / ml . Analysis proteolytic enzyme activity - zymography Will evaluate presence activity two proteolytic enzyme - MMP 9 ( gelatinase - degrades mainly collagen type IV ) MMP 8 ( collagenase - major degradation collagen type I , II , III ) three month completion debridement mechanical subgingival . For purpose use zymography technique . This technique base digestion association substrate verification molecular weight protease . It use identify proteolytic activity enzymes separate ( band ) polyacrylamide gel nonreducing condition . Gels stain Coomassie blue enzyme activity demonstrate absence coloration ( white streak ) area substrate degrade . Gel zymography : The gel zymography resemble gel electrophoresis also mount plate system . This gel compose two part : Starting gel gel separation . The two divide different position composition .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Patients smoker otherwise healthy patient initially diagnose moderate severe chronic periodontitis ( accord American Academy Periodontology AAP , 1999 ) verify presence radiographic periodontal pocket bone loss ; Patients least 4 bleed site probe depth ( PD ) &gt; 5 mm uniradiculares teeth . Presence minimum 20 teeth ; formal consent participate research , explain risk benefit individual involve . ( Resolution No . 196 October 1996 Dental Code Professional Ethics ( C.F.O . ) 179/93 ) . periapical pulp change Presence Presence systemic change use medication ( 6 month prior study ) may influence response periodontal treatment ( eg , phenytoin , cyclosporine , calcium channel antagonist , antiinflammatory steroid nonsteroidal ) ; Presence hypersensitivity tetracyclines derivative ; Teeth involvement fork case premolar . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Local Drug Delivery</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Doxycycline</keyword>
	<keyword>Smokers</keyword>
	<keyword>Chronic Periodontitis</keyword>
</DOC>